Escolar Documentos
Profissional Documentos
Cultura Documentos
Newsletter
December 2016
3
4
4
5
6
7
8
Words from
Stakeholders
Research Projects of
the members
Publications From the
Members
QoL Measurement
PERANTARA
Important note on the
WHOQOL-BREF
Recent Development
HRQOL In Indonesia
QOLMARI Membership
information
Dear reader,
Many developments took place since the first newsletter of QOLMARI. We had a
most successful seminar at the Universitas Pajadjaran (UNPAD) at September 8
and 9. Many national and international authorities were present and gave
lectures on the measurement and application of quality of life, for instance in
the area of the new National Health Insurance System and the monitoring of
people in poor or ill circumstances. Representatives from the Indonesian
Ministry of Health and from the WHO were present and showed their interest in
a new measurement tool for Indonesia, the EQ-5D-5L. You can read more about
these developments in this newsletter.
The QOLMARI found a basis of her activities in UNPAD, in particular in the
Faculty of Psychology, thanks to the willingness of its rector Prof. Dr. Tri
Hanggono Ahmad and the dean Dr. Hendriati Agustiani.
We welcome several new members. And last but not least: we have now our
own website (www.qolmari.org) enabling us to distribute this newsletter
digitally.
For the coming year 2017, important news can be expected. The norm data for
the EQ-5D-5L will be available, showing the ratings the Indonesian people give
to their different health states. Population-wide information on their quality of
life (QoL) is to be expected too. And several applications of QoL in poor people
and patient groups will be made public in scientific and policy domains. Of
course, we intend to organize a 2nd seminar to inform our group about these
results and its consequences for the society in more detail.
With these accomplishments of the QOLMARI and intentions for 2017, I wish you:
Page 2
QoLMARI News
The Introduction of The EuroQol EQ-5D-5L Value Set and Other Recent Developments in
Quality of Life Research and Cost-Effectiveness Analysis
Universitas Padjadjaran, 8-9 September 2016
On 8-9 September 2016, QOLMARI in collaboration with EuroQol Research Foundation and Faculty of Psychology
Universitas Padjadjaran organized a symposium titled A Big Step Forwards for Health Policy in Indonesia: The
Introduction of The EuroQol EQ-5D-5L Value Set and Other Recent Developments in Quality of Life Research and CostEffectiveness Analysis. This symposium started with the opening speech by Prof. Dr. med. Tri Hanggono Achmad, dr.,
Rector of Universitas Padjadjaran. The symposium was held in two subsequent sessions:
First, a session for policy makers conducted in the morning of the first day attended only by the officers of various
governmental bodies, especially health-related. In this first part, the speakers focused on health-related quality of life
(HRQOL) measurement and its value for health in Indonesia, the current HTA-related policies in Indonesia and the role
of economic evaluation in health care decision making. The final presentation followed by a discussion was the
introduction of Indonesian EQ-5D-5L value set.
Group picture
Second, a session for all participants started in the afternoon of the first day until the second day. Researchers from
prominent Indonesian (and from other countries) universities and clinicians from Indonesian academic hospitals involved
in (health-related) quality of life joined the policy makers. Most of the researchers were from medicine, psychology,
pharmacy, and health economics faculties. The first presentation was about the new Indonesian universal health care
(Jaminan Kesehatan Nasional/JKN), that started in 2014, and how HRQOL and health economics can help the Indonesian
citizens. The speakers afterwards focused more on the scientific, methodological aspects of HRQOL and its
measurement, whose values to be measured (i.e. general population, patients, or experts), cost-effectiveness analysis
and the role of the EQ-5D in HTA. The new Indonesian EQ-5D-5L value set was introduced (publication in preparation)
followed by a panel discussion session. Comparison between Asian countries in HTA and the use of EQ-5D were
presented in the second day. The afternoon session of the second day was for parallel class QOL-research presentations
where in total seven researchers presented their studies to the audiences.
In both sessions, the expert group on Quality of Life Measurement and its Application in the Republic Indonesia
(QOLMARI) was presented. We found a home base at Padjadjaran University and received several new members.
Group picture
QOLMARI would like to thank drg. Armansyah, MPPM, Prof. Dr. Jan Passchier, Prof. Dr. Jan van Busschbach, Francis
Ruiz, MSc, Dr. Nan Luo, and Fredrick D Purba, M.Psi., MSc for their invaluable knowledge sharing. We also greatly
appreciate the research presentations from Aulia Iskandarsyah, PhD, Dr. Dyah Aryani Perwitasari, Dr. Sri Susilawati
drg., M.Kes, Prof. Dr. Zulrizka Iskandar, MSc, Asteria Devy Kumalasari, M.Sc, and Titi Sahidah Fitriana, M.Psi. Both the
Padjadjaran University and the EuroQol Group were thanked for their support of this symposium.
QoLMARI News
Page 3
Page 4
QoLMARI News
QoLMARI News
Page 5
WHY USING QUALITY OF LIFE MEASURES IN OUR STUDY ON THE EFFECT OF A PSYCHO-EDUCATION
PROGRAM TO REDUCE DIAGNOSIS DELAY IN WOMEN WITH BREAST CANCER IN INDONESIA?
QOL measurement of the PERANTARA: an illustration
Aulia Iskandarsyah - Faculty of Psychology, University of Padjadjaran Indonesia
Jan Passchier - Faculty of Behaviour and Movement Sciences, VU University Amsterdam, the Netherlands
In our previous study, we informed you about our study in Bandung which develops and evaluates a self-help
educational program entitled PERANTARA (pengantar PERAwataN kesehaTan payudARA). Its purpose is to stimulate
women with breast cancer symptoms to come earlier to the hospital for getting a diagnosis. Because the faster the
diagnosis will be made, the faster the treatment can start and the higher the probability of recovery and also better
clinical outcomes. We have now finished this program, consisting of a booklet and video clip in a form of DVD. We
also got the cooperation of four hospitals for participation, and made a list of outcome measures to be used. The
PERANTARA provides the following information: 1) a brief explanation of breast cancer in order for the patients to
have an accurate understanding and stimulation to seek information from reliable sources (oncologist); 2) an
explanation of breast examination procedure to raise the patients awareness on their symptoms and willingness to
follow the procedure; 3) the recommendation to seek support from significant persons and institutions.
The short video features testimonies of two survivors who shared their stories about their conditions. The testimonies
highlight breast cancer survivors experience to promote modeling on their positive attitude and social support.
Among the outcome measures are two measures of quality of life: the WHOQOL-BREF and the EQ-5D-5L. The last
questionnaire is on Health-related Quality of Life. All measures will be filled in before the intervention or control
period, after the intervention and the control period, and at 3 months follow-up.
What is the reason for including measures for quality of life when you are focusing on the reduction of diagnosis
delay?
First, it is good to mention that our primary (i.e. most important) variable is diagnosis delay. So, the main conclusion
on the effectiveness of the PERANTARA is based on this outcome.
Second, the quality of life measures are included as secondary variables. Secondary implies less important than the
primary variable, that is because in our study reducing diagnosis delay is our most important point of interest. The
reason to measure these variables as well, is that we like to see which effect the PERANTARA has on the life of the
patients. Of course we hope that it will be positive, but we are not sure. At the one hand, you may expect that the
certainty of a diagnosis, of a good medical treatment and the support of the environment will increase the patients
well-being and health. At the other hand, there is also the possibility that a cancer diagnosis and the side effects of
cancer treatment result in feelings of anxiety and depression, and physical symptoms like nausea and hair loss. Of
course we expect that these negative consequences will diminish on the long run, but this requires a longer follow-up
than we are now able to perform.
Suppose that we find that the delay is not influenced, but the quality of life is improved. In that case we conclude
that the PERANTARA is not effective, unfortunately. But the positive findings on quality of life indicate that a next
study is warranted to test the effect of PERANTARA on quality of life as primary variable. Because increasing quality
of life is an purpose that is inherent to good medical treatment.
We look forward to see what happens, and will inform you about our findings again after one year.2
This study is carried out by: Hari Setyowibowo. Marit Sijbrandij. Aulia Iskandarsyah. Joke A. M. Hunfeld. Jan
Passchier. Sawitri S. Sadarjoen. Dharmayanti F. Badudu. Drajat R. Suardi
2
If you like to correspond about this article, please send your reaction to: j.passchier@vu.nl
Page 6
QoLMARI News
Suppose you buy a new laptop. The laptop is accompanied by a manual. Do you start with reading the manual? You
probably seldom do, you like to begin immediately with your recently acquired play-tool. Until the moment that you are
stuck and realize that it was better to have started by reading the manual first.
Same with questionnaires. In this note we like to share with you what we learned when applying the Indonesian version of
the WHOQOL-BREF.
First, there appear to be different English and Indonesian versions of the WHOQOL-BREF. For example, there is the
English version of 1998, which is attached to the manual of the WHOQOL-BREF as described in the WHO manual,
developed by Harper and Power. Next, there is the English version of WHOQOL-BREF 2004 as edited by the WHO and
distributed by the WHO, Geneva Switzerland.
The difference between the two English versions is that the 1998 version uses a time frame of 2 weeks: We ask that you
think about your life in the last two weeks. The 2004 version, however, uses a time frame of 4 weeks: We ask that you
think about your life in the last four weeks. The most recent Indonesian version of the WHOQOL-BREF is based on the
last one.
The manual of the WHOQOL-BREF allows differences in time frame (see p44 of the Manual 1998). Reasons for a different
timeframe might be the course of the disease of the patient of interest (for instance migraine is an affliction where the
attacks might happen only once a month) or a the wish of the researcher to compare the results with another
questionnaire that uses a four weeks time frame, such as the Health Status questionnaire Short-Form-36. Another
argument of a different time frame, might be the presence of cultural differences. For comparison between studies, it is
important that the researcher makes explicit which time frame he or she has applied and the reason why.
Anyway, it is good to note that the Indonesian version which is currently the official one uses the four weeks time frame.
Secondly, it is important to be attentive on the scoring of the WHOQOL-BREF. When we looked at the Indonesian
WHOQOL-BREF, we saw 3 negative items: Q3, Q4, and Q26. The scores on these items have to be reversed according to
the scoring key, so 1 becomes 5, 2 becomes 4 etc. This is indeed done when you look at the numbers accompanying the
alternatives of these questions, which range from 5 to 1 instead of from 1 to 5. However, at the end of the questionnaire
in the computations of the domain scores, it seemed if these corrections are made again by subtracting the scores from
number 6.
Such a double correction would imply a low number for a high quality of life regarding these items instead of a high
number for a high quality of life like in the other items. This seems not to be right.
Seeing the English version of 2004 on which it was based, this double (over)correction was also present.
However, approaching Prof Power, one of the authors of the manual, and reading the manual, revealed that the first
scoring key is meant for those who do the scoring of the WHOQOL-BREF manually. The second scoring key is for those who
do it by computer.
In order to avoid a confusion between the scoring by hand and by the computer, the Indonesian version applies the
same way of scoring for both, that is scoring each item in the same way (1 to 5) and correcting it for the negative items
afterwards.
For getting the WHO-Manual of 1998, we suggest you to approach Prof Power, National University of Singapore,
psypmj@nur.edu.sig
For getting the English WHOQOL-BREF version of 2004, you can approach their office in Geneva, Switzerland.
For getting the Indonesian WHOQOL-BREF version you can approach WHO field center WHOQOL instrument coordinator,
whoqol@who.int
If you have questions on this contribution, please send these to Jan Passchier: j.passchier@vu.nl
QoLMARI News
Page 7
Similar in some parts of the world, Health-Related Quality of Life (HRQOL) has become a very interesting subject in
Indonesia. This can be seen from activities such as conferences, seminars, panel discussions, and workshops
organized in some cities in Indonesia. In addition, research in HRQOL has been done in some Universities in
Indonesia. Meanwhile, as part of Pharmacoeconomics, HRQOL has been taught by some academicians throughout
Indonesia.
In spite of enthusiasm to explore more about HRQOL, some limitations still exist. Some classic reasons are underlying
in this matter. Among others, factors such as experts, literatures, and funds are needed to increase the level of
HRQOL in terms of research quality. More importantly, it is expected that development of HRQOL will affect health
policy in general and pharmaceutical policy in Indonesia.
With regard to pharmaceutical policy, research and study of HRQOL should give input in designing the policy. Such
input will broaden the perspective of pharmaceutical policy. To do that experts of HRQOL should convince policy
makers through research and studies which are of value for pharmaceutical policy.
Certainly the future of HRQOL in Indonesia is positive. The needs for applications of HRQOL will be increasing
particularly after Indonesia has a National Social Security System which is known as BPJS (Badan Penyelenggara
Jaminan Sosial). Although it is in the early stage, it is predicted that HRQOL research and study will give benefit for
the Indonesian people.
Terminology:
The rising of HRQOL research and study are positive in many ways. However, it is considered to be in its infancy.
Despite its early stage, terminology has become a serious discussion. Initially, quality of life has been accepted as
the common terminology. Later, Health-Related Quality of Life (HRQOL) is more preferred as it is more specific.
Sometimes HRQL is used interchangeably with Quality of Life (QOL). Meanwhile some experts are adopting Patient
Reported Outcomes (PROs).
Actually HRQOL itself is considered as having a loose definition. This is because a question is raised in terms of what
aspects of quality of life should be included. In fact, relevant aspects may vary from study to study. Some general
aspects such as physical functioning, general health, and physical symptom are popular among some experts.
One important aspect of HRQOL research and study in Indonesia, perhaps the most important one, is a cultural
matter. In this regard, single-item questions on these aspects of HRQOL as for global questions about overall HRQOL,
are likely to be ambiguous and unreliable. For this reason some experts prefer to develop questionnaires which are
multi-measurement scales for each concepts.
Topics:
In recent ISPOR Indonesia Chapter Conference which was held on 7 10 May 2016 in Jakarta, HRQOL has been an
important concept in Plenary Sessions. The aspect of HRQOL was included when topics such as Pharmacoeconomic
and Outcome Research for the future of Pharmacy were presented. HRQOL was also mentioned in topic presentations
such Universal Health Care: Case of Indonesia and its problem solving.
Meanwhile, short courses such HRQOL weights for economic evaluations and Patient-Report Outcome Measures
(PROMs): Development and Validation were given during ISPOR Indonesia Chapter Conference. These two subjects
were well attended.
In addition, a research project was done to explore HRQOL among breast cancer patients. Another interesting
research study was conducted in regard to HRQOL among diabetes type 2 patients, particularly comparing a group of
patients with physical exercise and a control group without physical exercise. These two researches are notably
interesting as these can stimulate future researches and studies about HRQOL for other diseases.
Page 8
QoLMARI News
QOLMARI MEMBERSHIP
Fredrick Dermawan Purba Secretary of QOLMARI Group
Dear readers,
It has been a year since the first QOLMARI newsletter circulated among its members. We believe that many non-members
also read that edition because we received many inquiries regarding the QOLMARI and its activities. During the quality of
life symposium at Universitas Padjadjaran on September 2016, many participants were expressing their interest to join
QOLMARI. Therefore in this second edition of QOLMARI newsletter, we would like to inform you the details of membership
as described below:
o
The membership is open for anyone who has interest in quality of life research and issues in Indonesia.
Any scientific background and level are welcomed as long as quality of life is part of the studies or interventions
conducted.
A curriculum vitae (pdf file), motivation letter (pdf file) and passport photo (jpg file) are three documents needed
to apply for membership.
The official website of QOLMARI: www.qolmari.org will provide a section for membership application in the end of
January 2017. Any interested applicant who wants to submit before the end of January 2017 can send an email with
the three documents attached to Fredrick Dermawan Purba: fredrick.purba@unpad.ac.id
We welcome you to join us in QOLMARI. If you like to have a contribution to the next Newsletter, please submit it to us.
Together we promote the quality of life research and applications in Indonesia to improve quality of life of Indonesian
people.
QoLMARI Group
Contact Person:
Fredrick Dermawan Purba (Secretary)
Phone:
+31107044789
E-mail:
fredrick.purba@unpad.ac.id